Erowid.org: Erowid Reference 705 : Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ('ecstasy') usage : Khakoo SI, Coles CJ, Armstrong JS, Barry RE

Erowid References Database

Khakoo SI, Coles CJ, Armstrong JS, Barry RE. “Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ('ecstasy') usage”. J Clin Gastroenterol. 1995;20(3):244-7. <a name="ref">Khakoo SI, Coles CJ, Armstrong JS, Barry RE.</a> <a href="/references/705">"Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ('ecstasy') usage"</a> <i>J Clin Gastroenterol</i>. 1995;20(3):244-7.
Text Abstract (this page) Full Text - English (private) Show Articles by Khakoo SI Coles CJ Armstrong JS Barry RE Article IDs Erowid RefID: 705 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract 3,4-Methylenedioxymetamphetamine ('ecstasy') has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]